Increased biliary transferrin excretion following parenteral aluminum administration to rats

G. L. Klein, R. M. Goldblum, M. Treinen Moslen, D. L. Pyron, P. A. Mann, T. C. Lee, A. C. Alfrey

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aluminum accumulates in the livers of patients receiving either parenteral nutrition of haemodialysis. When given parenterally to rats, aluminum causes cholestasis. However, the mechanism of hepatic aluminum uptake and the fate of aluminum in the liver are poorly understood. We examined the effect of parenteral aluminum administration on biliary excretion of transferrin, the major circulating aluminum-binding protein. Male Wistar rats were given parenterally aluminum 5 mg/kg/day for 1-14 days. Bile was collected for 3 hr at the end of the study period. Biliary total protein concentration and IgA/total protein were unaffected by up to 14 days of parenteral aluminum administration. However, biliary transferrin excretion increased with duration of aluminum administration up to five-fold by day 14. Biliary transferrin concentration and transferrin/total protein was higher in aluminum treated rats than controls after 7 and 14 days of study. Hepatic aluminum concentration reached a maximum after 4 days of parenteral aluminum administration, at which time serum bile acid and alanine amino transferase values were not different from controls. Since biliary transferrin is normally derived from the serum, it is likely that aluminum promotes hepatocellular uptake of transferrin and that aluminum enters the hepatocyte bound to transferrin. We postulate that transferrin may direct aluminum to intracellular sites where its toxic effects would be minimized.

Original languageEnglish (US)
Pages (from-to)373-376
Number of pages4
JournalPharmacology and Toxicology
Volume72
Issue number6
StatePublished - 1993

Fingerprint

Transferrin
Aluminum
Rats
Liver
Hepatobiliary Elimination
Rat control
Proteins
Poisons
Cholestasis
Parenteral Nutrition
Nutrition
Transferases
Bile Acids and Salts
Serum
Bile
Alanine
Immunoglobulin A
Renal Dialysis
Wistar Rats
Hepatocytes

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Pharmacology
  • Toxicology

Cite this

Klein, G. L., Goldblum, R. M., Treinen Moslen, M., Pyron, D. L., Mann, P. A., Lee, T. C., & Alfrey, A. C. (1993). Increased biliary transferrin excretion following parenteral aluminum administration to rats. Pharmacology and Toxicology, 72(6), 373-376.

Increased biliary transferrin excretion following parenteral aluminum administration to rats. / Klein, G. L.; Goldblum, R. M.; Treinen Moslen, M.; Pyron, D. L.; Mann, P. A.; Lee, T. C.; Alfrey, A. C.

In: Pharmacology and Toxicology, Vol. 72, No. 6, 1993, p. 373-376.

Research output: Contribution to journalArticle

Klein, GL, Goldblum, RM, Treinen Moslen, M, Pyron, DL, Mann, PA, Lee, TC & Alfrey, AC 1993, 'Increased biliary transferrin excretion following parenteral aluminum administration to rats', Pharmacology and Toxicology, vol. 72, no. 6, pp. 373-376.
Klein GL, Goldblum RM, Treinen Moslen M, Pyron DL, Mann PA, Lee TC et al. Increased biliary transferrin excretion following parenteral aluminum administration to rats. Pharmacology and Toxicology. 1993;72(6):373-376.
Klein, G. L. ; Goldblum, R. M. ; Treinen Moslen, M. ; Pyron, D. L. ; Mann, P. A. ; Lee, T. C. ; Alfrey, A. C. / Increased biliary transferrin excretion following parenteral aluminum administration to rats. In: Pharmacology and Toxicology. 1993 ; Vol. 72, No. 6. pp. 373-376.
@article{0a4c35b25a4d4c0c81d5240c26ecbd23,
title = "Increased biliary transferrin excretion following parenteral aluminum administration to rats",
abstract = "Aluminum accumulates in the livers of patients receiving either parenteral nutrition of haemodialysis. When given parenterally to rats, aluminum causes cholestasis. However, the mechanism of hepatic aluminum uptake and the fate of aluminum in the liver are poorly understood. We examined the effect of parenteral aluminum administration on biliary excretion of transferrin, the major circulating aluminum-binding protein. Male Wistar rats were given parenterally aluminum 5 mg/kg/day for 1-14 days. Bile was collected for 3 hr at the end of the study period. Biliary total protein concentration and IgA/total protein were unaffected by up to 14 days of parenteral aluminum administration. However, biliary transferrin excretion increased with duration of aluminum administration up to five-fold by day 14. Biliary transferrin concentration and transferrin/total protein was higher in aluminum treated rats than controls after 7 and 14 days of study. Hepatic aluminum concentration reached a maximum after 4 days of parenteral aluminum administration, at which time serum bile acid and alanine amino transferase values were not different from controls. Since biliary transferrin is normally derived from the serum, it is likely that aluminum promotes hepatocellular uptake of transferrin and that aluminum enters the hepatocyte bound to transferrin. We postulate that transferrin may direct aluminum to intracellular sites where its toxic effects would be minimized.",
author = "Klein, {G. L.} and Goldblum, {R. M.} and {Treinen Moslen}, M. and Pyron, {D. L.} and Mann, {P. A.} and Lee, {T. C.} and Alfrey, {A. C.}",
year = "1993",
language = "English (US)",
volume = "72",
pages = "373--376",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Increased biliary transferrin excretion following parenteral aluminum administration to rats

AU - Klein, G. L.

AU - Goldblum, R. M.

AU - Treinen Moslen, M.

AU - Pyron, D. L.

AU - Mann, P. A.

AU - Lee, T. C.

AU - Alfrey, A. C.

PY - 1993

Y1 - 1993

N2 - Aluminum accumulates in the livers of patients receiving either parenteral nutrition of haemodialysis. When given parenterally to rats, aluminum causes cholestasis. However, the mechanism of hepatic aluminum uptake and the fate of aluminum in the liver are poorly understood. We examined the effect of parenteral aluminum administration on biliary excretion of transferrin, the major circulating aluminum-binding protein. Male Wistar rats were given parenterally aluminum 5 mg/kg/day for 1-14 days. Bile was collected for 3 hr at the end of the study period. Biliary total protein concentration and IgA/total protein were unaffected by up to 14 days of parenteral aluminum administration. However, biliary transferrin excretion increased with duration of aluminum administration up to five-fold by day 14. Biliary transferrin concentration and transferrin/total protein was higher in aluminum treated rats than controls after 7 and 14 days of study. Hepatic aluminum concentration reached a maximum after 4 days of parenteral aluminum administration, at which time serum bile acid and alanine amino transferase values were not different from controls. Since biliary transferrin is normally derived from the serum, it is likely that aluminum promotes hepatocellular uptake of transferrin and that aluminum enters the hepatocyte bound to transferrin. We postulate that transferrin may direct aluminum to intracellular sites where its toxic effects would be minimized.

AB - Aluminum accumulates in the livers of patients receiving either parenteral nutrition of haemodialysis. When given parenterally to rats, aluminum causes cholestasis. However, the mechanism of hepatic aluminum uptake and the fate of aluminum in the liver are poorly understood. We examined the effect of parenteral aluminum administration on biliary excretion of transferrin, the major circulating aluminum-binding protein. Male Wistar rats were given parenterally aluminum 5 mg/kg/day for 1-14 days. Bile was collected for 3 hr at the end of the study period. Biliary total protein concentration and IgA/total protein were unaffected by up to 14 days of parenteral aluminum administration. However, biliary transferrin excretion increased with duration of aluminum administration up to five-fold by day 14. Biliary transferrin concentration and transferrin/total protein was higher in aluminum treated rats than controls after 7 and 14 days of study. Hepatic aluminum concentration reached a maximum after 4 days of parenteral aluminum administration, at which time serum bile acid and alanine amino transferase values were not different from controls. Since biliary transferrin is normally derived from the serum, it is likely that aluminum promotes hepatocellular uptake of transferrin and that aluminum enters the hepatocyte bound to transferrin. We postulate that transferrin may direct aluminum to intracellular sites where its toxic effects would be minimized.

UR - http://www.scopus.com/inward/record.url?scp=0027195482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027195482&partnerID=8YFLogxK

M3 - Article

VL - 72

SP - 373

EP - 376

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 6

ER -